NCT00528827View on ClinicalTrials.gov

A Randomized, Double-blinded, Placebo-controlled, Dose-ranging Study of Cardene® I.V. in Pediatric Subjects With Hypertension

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

September 30, 2007

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2008

Conditions
Hypertension
Interventions
DRUG

Cardene® I.V.

"* 5 mcg/kg/min Cardene I.V.~* 2.5 mcg/kg/min Cardene I.V.~* 0.5 mcg/kg/min Cardene I.V."

Trial Locations (2)

33145

Miami

90211

Beverly Hills

Sponsors

Lead Sponsor

Facet Biotech
All Listed Sponsors
lead

Facet Biotech

INDUSTRY

NCT00528827 - A Randomized, Double-blinded, Placebo-controlled, Dose-ranging Study of Cardene® I.V. in Pediatric Subjects With Hypertension | Biotech Hunter | Biotech Hunter